Allergy Therapeutics Earnings Calls

Dec 31, 2025
Release date Mar 31, 2026
EPS estimate -$0.0051
EPS actual -$0.0051
Revenue estimate 48.903M
Revenue actual 48.876M
Revenue Surprise -0.0551%
Sep 30, 2025
Release date Dec 11, 2025
EPS estimate -$0.0071
EPS actual -
Revenue estimate 28.848M
Revenue actual -
Jun 30, 2025
Release date Dec 11, 2025
EPS estimate -
EPS actual -$0.0071
Revenue estimate 32.906M
Revenue actual 28.848M
Revenue Surprise -12.33%
Dec 31, 2024
Release date Mar 31, 2025
EPS estimate -
EPS actual -$0.0029
Revenue estimate 42.575M
Revenue actual 42.576M
Revenue Surprise 0.0024%

Last 4 Quarters for Allergy Therapeutics

Below you can see how AGYTF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Dec 31, 2024
Release date Mar 31, 2025
Price on release $0.100
EPS estimate -
EPS actual -$0.0029
Date Price
Mar 25, 2025 $0.0520
Mar 26, 2025 $0.0520
Mar 27, 2025 $0.0520
Mar 28, 2025 $0.0520
Mar 31, 2025 $0.100
Apr 01, 2025 $0.100
Apr 02, 2025 $0.100
Apr 03, 2025 $0.100
Apr 04, 2025 $0.100
4 days before 92.31%
4 days after 0%
On release day 0%
Change in period 92.31%
Jun 30, 2025
Release date Dec 11, 2025
Price on release $0.110
EPS estimate -
EPS actual -$0.0071
Date Price
Dec 05, 2025 $0.110
Dec 08, 2025 $0.110
Dec 09, 2025 $0.110
Dec 10, 2025 $0.110
Dec 11, 2025 $0.110
Dec 12, 2025 $0.110
Dec 15, 2025 $0.110
Dec 16, 2025 $0.110
Dec 17, 2025 $0.110
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%
Sep 30, 2025
Release date Dec 11, 2025
Price on release $0.110
EPS estimate -$0.0071
EPS actual -
Date Price
Dec 05, 2025 $0.110
Dec 08, 2025 $0.110
Dec 09, 2025 $0.110
Dec 10, 2025 $0.110
Dec 11, 2025 $0.110
Dec 12, 2025 $0.110
Dec 15, 2025 $0.110
Dec 16, 2025 $0.110
Dec 17, 2025 $0.110
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%
Dec 31, 2025
Release date Mar 31, 2026
Price on release $0.110
EPS estimate -$0.0051
EPS actual -$0.0051
Date Price
Mar 25, 2026 $0.110
Mar 26, 2026 $0.110
Mar 27, 2026 $0.110
Mar 30, 2026 $0.110
Mar 31, 2026 $0.110
Apr 01, 2026 $0.110
Apr 02, 2026 $0.110
Apr 06, 2026 $0.110
Apr 07, 2026 $0.110
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%

Allergy Therapeutics Earnings History

Earnings Calendar

FAQ

When is the earnings report for AGYTF?
Allergy Therapeutics plc (AGYTF) has scheduled its earnings report for Sep 30, 2026 after the markets close.

What is the AGYTF price-to-earnings (P/E) ratio?
AGYTF P/E ratio as of Jun 22, 2026 (TTM) is -7.33.

What is the AGYTF EPS forecast?
The forecasted EPS (Earnings Per Share) for Allergy Therapeutics plc (AGYTF) for the first fiscal quarter 2026 is $.

What are Allergy Therapeutics plc's retained earnings?
On its balance sheet, Allergy Therapeutics plc reported retained earnings of $48.88 million for the latest quarter ending Dec 31, 2025.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT ALLERGY THERAPEUTICS PLC
Allergy Therapeutics
Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, P...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE